HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE , an artif...
Japan-headquartered pharmaceutical firm Takeda and Swiss firm AC Immune SA have announced an exclusive, worldwide o...
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.64 bill...
The Japan Kidney Association, a nonprofit organisation, and Renalys Pharma, Inc., have entered into a collaborat...
Takara Bio USA, Inc., a wholly owned subsidiary of Japan-headquartered Takara Bio Inc., has announced the launch of the ...
Anaut Inc., a pioneering developer in surgical support software led by Dr Nao Kobayashi, has announced the regulato...
Japan-based PeptiDream Inc has announced an expansion of its peptide discovery collaboration with Swiss-based firm&...
Câ‚‚N Diagnostics, a specialty diagnostics company with a vision to bring Clarity Through Innovation, has announced...
Japanese multinational company Yokogawa Electric Corporation’s latest single-cell analysis solution, the Single Ce...
Japanese Foundation for Cancer Research (JFCR) and Takeda Pharmaceutical have signed a partnership agreement with the go...
Takeda Pharmaceutical, Astellas Pharma and Sumitomo Mitsui Banking Corporation (SMBC), in Japan, have signed a master ag...
Japan-headquartered Shimadzu Corporation and Tohoku University have opened the Shimadzu × Tohoku University Supers...
Eisai Co. has announced that the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (pera...
Japanese pharma behemoth Shionogi & Co. has announced that its group company Taiwan Shionogi has received approv...
Nanoform Finland Plc has announced a strategic partnership whereby CBC Co. will utilise its extensive experience in the ...
The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to tre...
Japan-headquartered Canon Medical Systems Corporation and Hiroshima University have begun clinical research, using a Can...
Japan headquartered pharma company Eisai Co. has announced that its French sales subsidiary Eisai S.A.S. has entered int...
Japan-based Mitsui & Co., has decided to acquire shares in Eu Yan Sang International (EYS) jointly with Rohto Pharma...
Japan headquartered Shimadzu Corporation has acquired all shares of California X-ray Imaging Services, Inc. (CIS) throug...
NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has ente...
AW Technologies and Asahi Kasei Medical, a core operating company of the Japanese technology company Asahi Kasei, have e...
Eisai Co. has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ...
Nippon Shinyaku and Eli Lilly Japan K.K have entered into an alliance agreement in Japan for pirtobrutinib, which ...
